Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies

Clinical trial NCT01242072 · UNKNOWN

Trial details

NCT number: NCT01242072
Sponsor: Alaunos Therapeutics
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Malignancy Cancer Non Small Cell Lung Cancer Small Cell Lung Cancer Testicular Cancer Thymoma Ovarian Cancer Osteosarcoma

Start date: 2010-11-01
Primary completion: 2012-12-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.